Literature DB >> 310840

Requirements for mitogenic stimulation of murine B cells by soluble anti-IgM antibodies.

C L Sidman, E R Unanue.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 310840

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

Review 1.  ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery.

Authors:  N Isakov
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

2.  B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.

Authors:  K Oliver; R J Noelle; J W Uhr; P H Krammer; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

3.  Dissociation of two signals required for activation of resting B cells.

Authors:  M H Julius; H von Boehmer; C L Sidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution.

Authors:  A Marcuzzi; B Van Ness; T Rouse; D Lafrenz
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

5.  ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.

Authors:  Y Tagaya; Y Maeda; A Mitsui; N Kondo; H Matsui; J Hamuro; N Brown; K Arai; T Yokota; H Wakasugi
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

6.  Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.

Authors:  B Subbarao; D E Mosier
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

7.  Activation of murine B lymphocytes by anti-immunoglobulin is an inductive signal leading to immunoglobulin secretion.

Authors:  D C Parker; D C Wadsworth; G B Schneider
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.